1. Optovue

    0 Comments Leave a Comment

    1-15 of 510 1 2 3 4 ... 32 33 34 »
    1. Mentioned In 510 Articles

    2. HS-UK launch Optovue’s innovative DualTrac and Vault Mapping technology in the UK

      HS-UK launch Optovue’s innovative DualTrac and Vault Mapping technology in the UK
      DualTrac Motion Correction is a unique technology which provides motion correction at two levels. It combines video tracking and Motion Correction Technology (MCT) to enable true 3D tracking. The first level provides real-time correction for rapid eye movements, blinking or eye drifting, which improves patient comfort. The second level occurs during post-processing of imaging and corrects smaller levels of motion distortion. This combined approach results in reliable motion correction for ...
      Read Full Article
      Mentions: Optovue Haag-Streit
    3. Retinal and Macular Ganglion Cell Count Estimated With Optical Coherence Tomography RTVUE-100 as a Candidate Biomarker for Glaucoma

      Retinal and Macular Ganglion Cell Count Estimated With Optical Coherence Tomography RTVUE-100 as a Candidate Biomarker for Glaucoma
      Purpose : To evaluate the ability of total and macular estimated retinal ganglion cell (RGC) counts to discriminate between healthy and glaucomatous eyes. To determine threshold markers of the estimated RGCs taking into account age dependence. Methods : This was a cross-sectional, observational study. The study group consisted of 176 eyes subdivided in three groups: 32 healthy, 91 preperimetric (PPG), and 53 primary open-angle glaucoma (POAG) eyes. The estimate of total and ...
      Read Full Article
      Mentions: Optovue
    4. QUALITATIVE AND QUANTITATIVE FOLLOW-UP USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF RETINAL VEIN OCCLUSION TREATED WITH ANTI-VEGF: Optical Coherence Tomography Angiography Follow-up of Retinal Vein Occlusion

      QUALITATIVE AND QUANTITATIVE FOLLOW-UP USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF RETINAL VEIN OCCLUSION TREATED WITH ANTI-VEGF: Optical Coherence Tomography Angiography Follow-up of Retinal Vein Occlusion
      ...est-corrected visual acuity, spectral domain optical coherence tomography, fluorescein angiography, and OCTA (Optovue, Inc). Automatic measurement of vascular density of the superficial and deep capillary plexus was also...
      Read Full Article
    5. Comparison of Several Parameters in Two Optical Coherence Tomography Systems for Detecting Glaucomatous Defects in High Myopia

      Comparison of Several Parameters in Two Optical Coherence Tomography Systems for Detecting Glaucomatous Defects in High Myopia
      Purpose : To compare the diagnostic powers of parameters of the RTVue and Cirrus-HD optical coherence tomography (OCT) systems in detecting glaucoma in highly myopic eyes. Methods : For this study, 28 glaucoma patients with high myopia (HM-G) and 28 high-myopia controls (HM-C) were enrolled. The circumpapillary retinal nerve fiber layer (cp-RNFL) and ganglion cell complex (GCC) parameters in the RTVue-OCT, and the ganglion cellinner plexiform layer (GCIPL) and cp-RNFL parameters in ...
      Read Full Article
    6. Fractal Dimensional Analysis of Optical Coherence Tomography Angiography in Eyes With Diabetic Retinopathy

      Fractal Dimensional Analysis of Optical Coherence Tomography Angiography in Eyes With Diabetic Retinopathy
      Purpose : We used fractal dimensional analysis to analyze retinal vascular disease burden in eyes with diabetic retinopathy using spectral-domain optical coherence tomography angiography (OCTA). Methods : A retrospective study was performed of 13 eyes with diabetic retinopathy without diabetic macular edema and 56 control eyes. Optical coherence tomography angiography images were acquired using the RTVue XR Avanti. Automated segmentation was obtained through the superficial and deep capillary plexuses for each eye ...
      Read Full Article
    7. Evaluation of artifact reduction in optical coherence tomography angiography with real-time tracking and motion correction technology

      Evaluation of artifact reduction in optical coherence tomography angiography with real-time tracking and motion correction technology
      Artifacts introduced by eye motion in optical coherence tomography angiography (OCTA) affect the interpretation of images and the quantification of parameters with clinical value. Eradication of such artifacts in OCTA remains a technical challenge. We developed an algorithm that recognizes five different types of motion artifacts and used it to evaluate the performance of three motion removal technologies. On en face maximum projection of flow images, the summed flow signal ...
      Read Full Article
    8. 1-15 of 510 1 2 3 4 ... 32 33 34 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Optovue

    Optovue

    Optovue.  Ophthalmology Systems.  Optovue, Inc., is a privately-held ophthalmic diagnostic company located in Fremont, California. Optovue was founded in 2003 by ophthalmic industry veterans, including developers of the time-domain optical coherence tomography (OCT) devices sold by Carl Zeiss Meditec (Humphrey), such as Stratus™ and Visante™. Optovue is backed by experienced technology and healthcare venture capital firms and private investors.

  3. Quotes about Optovue

    1. Our customers around the world provided a 19% revenue increase for 2009 over 2008...We have continuing strong support by representatives and distributor's world-wide, and all regions including the US are up significantly from 2008. The first fiscal quarter of 2010 demonstrated still another significant increase over 2009 numbers. The trend is clearly demonstrating that the clinical package offered by Optovue products is still highly desirable when faced with a number of product options.
      Gordon Wong in Optovue Announces 19% 2009 Revenue Increase Over 2008
    2. Gaining market share in the home country where Optovue manufactures is always satisfying...“Gaining market share in the home country where Optovue manufactures is always satisfying...The mission in 2012 is to continue our market growth world-wide utilizing our new TCP (Total Cornea Power) and V TRAC (Eye Tracking) options; as well as expand our iWellness programs.
      In Optovue Announces US sales orders for advanced OCT up 32% over previous year
    3. Haag-Streit is happy to partner with Optovue for its leadership in OCT technology and outstanding customer service. Our bundled technologies will create an advanced package that will provide a superior diagnostic tool to the ophthalmic industry.
      In Haag-Streit USA and Optovue Team Up to Introduce Octopus/Optovue Bundle